Zipnosis is a leading virtual care software company that offers a profoundly simple platform to treat and triage patients for common health conditions.

Zipnosis's platform pairs traditional telemedicine with next-generation online virtual care tools to drive exceptional clinical quality, significant clinical efficiency and durable financial returns.

Zipnosis was founded in 2008 by Jon Pearce and is based in Minneapolis, Minnesota.

Zipnosis's intelligent algorithms powering the asynchronous platform include curated diagnosis and treatment pathways, e-prescribing software and organic clinical decision support to enhance antibiotic prescribing prudence and patient health outcomes.

Zipnosis also offers a ZipTicket, a healthcare boarding pass that provides patients with access to clinics for in-person assessments or lab tests.


Zipnosis is pioneering online adaptive interview technology, which is built on a foundation of clinical best practice guidelines. This smart alternative to traditional telemedicine allows providers to diagnose and develop a treatment plan for patients in just two minutes.


Zipnosis is backed by investors including Safeguard Scientifics, Arthur Ventures, Fairview Health Services, & Ascension Ventures among others.



  • Year founded: 2008
  • Funding Info: $24.8M in 5 Funding Rounds (Last Funding Type: Series B)
  • Yearly Revenue: $10M-$20M (2018)
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Minneapolis
  • State: Minnesota
  • Country: United States
Related businesses